Screener
Axsome Therapeutics AXSM Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Axsome Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Axsome Therapeutics’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 5:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204274
FAQ
- What is Axsome Therapeutics's operating margin?
- Axsome Therapeutics (AXSM) reported operating margin of -24.4% in Q1 2026.
- How has Axsome Therapeutics's operating margin changed year-over-year?
- Axsome Therapeutics's operating margin increased by 60.9% year-over-year, from -62.5% to -24.4%.
- What is the long-term trend for Axsome Therapeutics's operating margin?
- Over 3 years (2022 to 2025), Axsome Therapeutics's operating margin has grown at a -58.3% compound annual growth rate (CAGR), from -359.3% to -26.1%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Axsome Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude